(United kingdom / English)

Medical News Today spoke with Prof. Thomas Elias Cocolios, from KU Leuven’s Department of Physics and Astronomy in Belgium. His cancer research takes place in what one might consider an unlikely venue: the European Organization for Nuclear Research (CERN). He told us how MEDICIS “uses a mass separation technique that allows [it] to produce carrier-free radioisotopes with very high specific activities, which are appropriate for nuclear medicine applications